Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
asciminib
×
Clear all
Filters
2
NCT04877522
2026-03-06
Asciminib Roll-over Study
Novartis
Phase 4
Recruiting
347 enrolled
NCT05456191
2026-02-06
ASC4START
Novartis
Phase 3
Active not recruiting
568 enrolled